Cargando…

A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults

OBJECTIVE: To evaluate single zuranolone (SAGE‐217) 30 or 45 mg doses in a 5‐h phase advance insomnia model. METHODS: In this double‐blind, three‐way crossover study, healthy adults received placebo (n = 41), zuranolone 30 mg (n = 44), and zuranolone 45 mg (n = 42) across three treatment periods. Sl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bullock, Amy, Gunduz‐Bruce, Handan, Zammit, Gary K., Qin, Min, Li, Haihong, Sankoh, Abdul J., Silber, Christopher, Kanes, Stephen J., Jonas, Jeffrey, Doherty, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286466/ https://www.ncbi.nlm.nih.gov/pubmed/34352138 http://dx.doi.org/10.1002/hup.2806

Ejemplares similares

Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial
por: Deligiannidis, Kristina M., et al.
Publicado: (2021)

SAGE-217, A Novel GABA(A) Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies
por: Hoffmann, Ethan, et al.
Publicado: (2019)

Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABA(A) receptor positive allosteric modulator
por: Althaus, Alison L., et al.
Publicado: (2020)

Rapid improvements in MADRS with zuranolone in major depressive disorder and postpartum depression: results from the LANDSCAPE/NEST clinical development programmes
por: Clayton, A. H., et al.
Publicado: (2023)

Clinical Efficacy of a 2-Week Treatment Course of Zuranolone for the Treatment of Major Depressive Disorder and Postpartum Depression: Outcomes From the Clinical Development Program
por: Clayton, A., et al.
Publicado: (2022)

Pharmacokinetics, safety, and tolerability of single and multiple doses of zuranolone in Japanese and White healthy subjects: A phase 1 clinical trial
por: Sonoyama, Takuhiro, et al.
Publicado: (2023)

Foreword: INDEPTH WHO-SAGE study
por: Sankoh, Osman
Publicado: (2010)

Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial
por: Rosenberg, Russell, et al.
Publicado: (2019)

Efficacy and safety of zuranolone in major depressive disorder: a meta-analysis of factor effect and dose-response analyses
por: Lin, Yu-Wei, et al.
Publicado: (2023)

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer—a double-blind, randomized placebo-controlled clinical multicenter phase IV trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2022)

Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
por: Kärppä, Mikko, et al.
Publicado: (2020)

Comparison of sleep microarchitecture in screen failure subjects with insomnia complaints and randomized subjects from two phase 3 studies on insomnia disorder
por: Di Marco, T., et al.
Publicado: (2023)

Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study
por: Uchiyama, Makoto, et al.
Publicado: (2022)

Better than sham? A double-blind placebo-controlled neurofeedback study in primary insomnia
por: Schabus, Manuel, et al.
Publicado: (2017)

Attentional bias modification training for insomnia: A double-blind placebo controlled randomized trial
por: Lancee, Jaap, et al.
Publicado: (2017)

Nest Success of Gunnison Sage-Grouse in Colorado, USA
por: Davis, Amy J., et al.
Publicado: (2015)

The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial
por: Abbasi, Behnood, et al.
Publicado: (2012)

Effect of Acupuncture on Pregnancy-Related Insomnia and Melatonin: A Single-Blinded, Randomized, Placebo-Controlled Trial
por: Foroughinia, Saeedeh, et al.
Publicado: (2020)

Acupuncture treatment of hypertension with insomnia: A protocol for randomized, double-blind, placebo controlled trial research
por: Zhu, Xun, et al.
Publicado: (2022)

Sage for undergraduates
por: Bard, Gregory V
Publicado: (2015)

Sage in Hyperidrosis
Publicado: (1897)

The Vagabond Sage
Publicado: (1881)

An introduction to SAGE programming: with applications to SAGE interacts for numerical methods
por: Mezei, Razvan
Publicado: (2015)

Memorandum: I217 update
por: CERN. Geneva. SPS-PS Experiments Committee
Publicado: (1999)

Health Tract, No. 217: Hunger
Publicado: (1865)

Health Tract, No. 217: Hunger
Publicado: (1864)

Clinics in diagnostic imaging (217)
por: Ong, Wu Lin Low, et al.
Publicado: (2023)

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
por: Goadsby, Peter J, et al.
Publicado: (2019)

Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
por: Hu, Bo, et al.
Publicado: (2022)

Refractory Insomnia in an Adolescent with Total Blindness
por: Tubbs, Andrew S., et al.
Publicado: (2019)

Sleep phase and pre-sleep arousal predicted co-developmental trajectories of pain and insomnia within adolescence
por: Arnison, Tor, et al.
Publicado: (2022)

Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels
por: Wennström, Malin, et al.
Publicado: (2022)

Sage Timeslips for dummies
por: Marmel, Elaine J
Publicado: (2014)

The SAGE companion to the city
Publicado: (2008)

Sage Tea for Hiccough
por: Howard, N. F.
Publicado: (1895)

Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study
por: Hernández-Ojeda, Jaime, et al.
Publicado: (2014)

A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
por: Murakami, Masato, et al.
Publicado: (2015)

Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double‐Blind, Phase II Trial
por: Cohen, Stanley, et al.
Publicado: (2020)

Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
por: Deodhar, Atul, et al.
Publicado: (2021)

Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
por: Yosipovitch, Gil, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kd08fme3gmk51gijmqv6qc7930